| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/12/2004 | US20040157329 Transfecting chondrocytes and other mesenchymal cells with vectors comprising genes capable of stimulating chondrogenesis, osteogenesis, growth, repair, regeneration and/or restoration of the cellular matrix |
| 08/12/2004 | US20040157324 Method for maintenance and propagation of germline stem cells using members of the TGF-beta family of growth factors |
| 08/12/2004 | US20040157314 Inhibitors of Staphylococcus aureus primary sigma factor and uses thereof |
| 08/12/2004 | US20040157313 Ammonia-oxidizing bacteria |
| 08/12/2004 | US20040157312 capable of conferring resistance to different bacteria used in fermentation processes; genetic engineering |
| 08/12/2004 | US20040157310 Methods for enhancing the production of viral vaccines in cell culture |
| 08/12/2004 | US20040157308 Alpha-galactosidase as food-grade genetic marker |
| 08/12/2004 | US20040157307 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits |
| 08/12/2004 | US20040157305 obtained from Rhodococcus; biocatalyst; stereospecific alcohol dehydrogenase activity in the oxidation of secondary alcohols or the reduction of ketones |
| 08/12/2004 | US20040157303 Novel Escherichia coli having accession no PTA 1579 and its use to produce polyhydroxybutyrate |
| 08/12/2004 | US20040157300 Glycoprotein vi fusion proteins |
| 08/12/2004 | US20040157299 by transducing the tumor cells with a herpes simplex virus amplicon containing the gene for an immunomodulating protein; for multi-transduced cells for multi-targeted therapy; genetic engineering |
| 08/12/2004 | US20040157297 for drug screening anticancer agents using animal models; biochips; genetic engineering |
| 08/12/2004 | US20040157296 Canine and feline B7-2 proteins, compositions and uses thereof |
| 08/12/2004 | US20040157292 Sperm-specific cation channel, CatSper1, and uses therefor |
| 08/12/2004 | US20040157291 expressed sequence tag (EST); of fusion proteins comprising the first N-terminal domain of the geneIII protein of filamentous phage as fusion partner for the expression of a fused (poly)peptide/protein |
| 08/12/2004 | US20040157290 Process for preparing serine-rich protein employing cysteine synthase (cysK) gene |
| 08/12/2004 | US20040157288 Substances |
| 08/12/2004 | US20040157287 Gene switches; polypeptides and promoter; induce transcription |
| 08/12/2004 | US20040157286 Process for producing coenzymes q10 |
| 08/12/2004 | US20040157282 Regulation of human dual specificity protein phosphatase 7-like protein |
| 08/12/2004 | US20040157279 Methods of analysis and labeling of protein-protein interactions |
| 08/12/2004 | US20040157269 Function homology screening |
| 08/12/2004 | US20040157263 biosensor for environmental analysis, the food industry, human and veterinary diagnosis, crop protection; solid phase synthesis |
| 08/12/2004 | US20040157261 Kv10.1, a novel voltage-gated potassium channel from human brain |
| 08/12/2004 | US20040157259 Novel human ion channel protein and polynucleotides encoding the same |
| 08/12/2004 | US20040157258 Isolated nucleic acid comprising polynucleotide of given sequence; screening methods for identifying binding partners of polypeptides; use in diagnosis and treatment |
| 08/12/2004 | US20040157256 Nucleotide sequence is artificially added to the 3'-side of an antisense strand; immobilization using complementary primer |
| 08/12/2004 | US20040157250 Contacting a test compound with an expression system comprising an ABCA1 polynucleotide and detecting a change; use in treating coronary artery disease |
| 08/12/2004 | US20040157248 With a deletion of at least 13-20 amino acids residues from the carboxyl terminus; highly proficient in both the ssDNA binding protein from E. coli, SSB displacement and steady state binding of DNA in the presence or absence of SSB as compared to the wild-type protein; increasing recombination efficiency |
| 08/12/2004 | US20040157246 Purified protein encoded by a nucleic acid hybridizable to a DNA of given sequence; use in diagnosis, prognosis and screening for a disposition to cardiovascular disorders |
| 08/12/2004 | US20040157244 Process for purification of plasmid DNA |
| 08/12/2004 | US20040157239 Endonuclease capable of cleaving DNA from divalent cations, which retains its activity in acidic to neutral pH range, and is not inhibited by G-actin; treatment of cystic fibrosis |
| 08/12/2004 | US20040157238 At a polymorphic site; contacting labeled amplicons with hybridization probes; comparing wild type and variant complexes; assay kit |
| 08/12/2004 | US20040157236 Multitemperature single strand conformation polymorphism (MSSCP) |
| 08/12/2004 | US20040157232 for inhibiting apoptosis in mammalian cells; zinc finger domains; consensus sequences; genetic engineering; for treating AIDS, alzheimer's disease, parkinson's disease, amyotrophic lateral sclerosis (ALS), retinitis pigmentosa, autoimmune diseases |
| 08/12/2004 | US20040157230 non-radioactive assay in microtiter plate format enabling colorimetric or fluorimetric product detection for drug screening; solid phase synthesis |
| 08/12/2004 | US20040157229 Methods of profiling gene expression, protein or metabolite levels |
| 08/12/2004 | US20040157224 no harmful organic solvents are involved, that physical and biochemical degradation/digestion of nucleic acids during the isolation process is minimized |
| 08/12/2004 | US20040157223 Chemical treatment of biological samples for nucleic acid extraction and kits therefor |
| 08/12/2004 | US20040157222 for drug screening anti-cancer, asthma, obesity, diabetes, central nervous system and cardiovascular disorder drugs; genetic engineering; kits |
| 08/12/2004 | US20040157219 comprises an alkaline agent, at least one detergent, and a suspension of paramagnetic particles and an acidic solution |
| 08/12/2004 | US20040157216 Polypeptides having a functional domain of interest and methods of identifying and using same |
| 08/12/2004 | US20040157215 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 08/12/2004 | US20040157214 comprises a filamentous bacteriophage particle displaying on its surface a binding molecule which has a binding domain able to bind target epitope or antigen; genetic engineering |
| 08/12/2004 | US20040156929 Rice cultivar C3GHi |
| 08/12/2004 | US20040156909 especially amphiphilic cationic or anionic vinyl ether polymers (e.g., copolymerized with maleic anhydride) electrostatically or covalently attached to the polynucleotide |
| 08/12/2004 | US20040156890 Polycationic sterol derivatives as transfection agents |
| 08/12/2004 | US20040156866 Leishmania infantum P36 protein or immunogenic fragment optionally in combination with a compound stimulating the production of a Th1-type cellular immune response |
| 08/12/2004 | US20040156864 Immunogenic HBc chimer particles having enhanced stability |
| 08/12/2004 | US20040156863 administering chimeric, carboxy-terminal truncated hepatitis B virus nucleocapsid (core) protein that is engineered for both enhanced stability of self-assembled particles and the substantial absence of nucleic acid binding by those particles |
| 08/12/2004 | US20040156858 yeast vehicle; and a fusion protein of a cancer antigen and a peptide having amino acid residues that are heterologous to the cancer antigen that stabilizes expression of the fusion protein or prevents posttranslational modification |
| 08/12/2004 | US20040156848 Therapeutic uses of factors which inhibit or neutralize MIF activity |
| 08/12/2004 | US20040156845 DNA encoding a human histamine receptor of the H3 subtype |
| 08/12/2004 | US20040156841 Human amine transporter |
| 08/12/2004 | US20040156838 inducing cytotoxic T-lymphocytes that will specifically down-regulate B-cells producing autologous IgE, notably by means of nucleic acid vaccination or live vaccination; inducing a combined antibody and CTK response specific for IgE |
| 08/12/2004 | US20040156832 vector for reverting cell lines to a pro-B cell-like state or to a germline-like state; generating immunoglobulins including immunoglobulin heavy and/or light chains and generating libraries of cells that produce arrays of immunoglobulins |
| 08/12/2004 | US20040156830 Vector and pharmaceutical composition containing cell death inducing gene |
| 08/12/2004 | US20040156828 Adeno-associated virus mediated B7.1 vaccination synergizes with angiostatin to eradicate disseminated liver metastatic cancers |
| 08/12/2004 | US20040156827 Recombinant adenoviral vectors and their utility in the treatment of various types of fibrosis: hepatic, renal, pulmonary, as well as hypertrophic scars |
| 08/12/2004 | DE10352668A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Methylotrophen A process for the preparation of L-amino acids using methylotrophs |
| 08/12/2004 | DE10303937A1 Pflanzentransformation mit Assemblierung einer gewünschten Sequenz in Vivo Assembly plant transformation with a desired sequence in Vivo |
| 08/12/2004 | DE10303664A1 Erkennungsmoleküle zur Behandlung und Detektion von Tumoren Recognition molecules for the treatment and detection of tumors |
| 08/12/2004 | DE10256083A1 Expressionsvektor, Verfahren zur Herstellung von heterologen Genprodukten und Selektionsverfahren für hochproduzierende rekombinante Zellen Expression vector, method for the production of heterologous gene products and selection process for high producing recombinant cells |
| 08/12/2004 | CA2514937A1 Paramyxoviral vectors encoding ribozymes and uses thereof |
| 08/12/2004 | CA2514934A1 Methods of identifying and designing cell surface receptor inhibitors |
| 08/12/2004 | CA2514666A1 Ires |
| 08/12/2004 | CA2514580A1 Compositions and methods of tolerizing a primate to an antigen |
| 08/12/2004 | CA2514536A1 Down-regulation of target-gene with pei/single-stranded oligoribonucleotide complexes |
| 08/12/2004 | CA2514517A1 Use of meganucleases for inducing homologous recombination ex vivo and in toto in vertebrate somatic tissues and application thereof |
| 08/12/2004 | CA2514417A1 Custom-made meganuclease and use thereof |
| 08/12/2004 | CA2514062A1 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | CA2514041A1 Mixing and matching tc proteins for pest control |
| 08/12/2004 | CA2513699A1 Means for regulating the expression of human isoforms of ant |
| 08/12/2004 | CA2513590A1 Production of 5'-ribonucleotides |
| 08/12/2004 | CA2513398A1 Antisense oligonucleotides that inhibit expression of hif-1 |
| 08/12/2004 | CA2512161A1 Hyperthermia oncolysis co-therapy |
| 08/12/2004 | CA2511927A1 Method of preparing a vaccine and anti-tumor vaccines |
| 08/12/2004 | CA2510484A1 Xylose-fermenting recombinant yeast strains |
| 08/12/2004 | CA2510482A1 Recombinant hepatitis a virus antigens obtained in plant cells |
| 08/12/2004 | CA2509136A1 Human il-1 beta antagonists |
| 08/12/2004 | CA2508340A1 Transcriptional activator |
| 08/12/2004 | CA2485568A1 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | CA2457607A1 Method of mutagenic chain reaction |
| 08/11/2004 | EP1445609A1 Base sequencing electrode, base sequencing device and base sequencing method |
| 08/11/2004 | EP1445331A1 Molecular biological identification techniques for microorganism |
| 08/11/2004 | EP1445330A1 Probe medium and method of producing the same |
| 08/11/2004 | EP1445325A1 Processes for producing isomaltose and isomaltitol and use thereof |
| 08/11/2004 | EP1445323A1 Process for production of glutamic acid derivatives |
| 08/11/2004 | EP1445322A1 Packaging systems for human recombinant adenovirus to be used in gene therapy |
| 08/11/2004 | EP1445321A1 Maize embryo-specific promoter compositions and methods for use thereof |
| 08/11/2004 | EP1445320A1 Automated gene-targeting using non-toxic detectable markers |
| 08/11/2004 | EP1445319A1 Gene of enzyme reactivating dna damaged by ultraviolet light using visible light |
| 08/11/2004 | EP1445318A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2004 | EP1445317A2 Compositions and methods for the diagnosis and treatment of tumor |
| 08/11/2004 | EP1445316A1 Novel secreted protein |
| 08/11/2004 | EP1445315A1 Human and mammalian stem cell-derived neuronal survival polypeptides |
| 08/11/2004 | EP1445314A1 Novel glutamic acid receptor and utilization thereof |
| 08/11/2004 | EP1445313A1 METHOD OF DETECTING AND QUANTIFYING HEMOLYSIN-PRODUCING BACTERIA BY OVERWHELMINGLY DETECTING AND QUANTIFYING THERMOSTABLE HEMOLYSIN-RELATED GENES (tdh-RELATED HEMOLYSIN GENES) OF FOOD POISONING BACTERIA |
| 08/11/2004 | EP1445312A1 Method of inhibiting gene expression |